CD5+ B cells in autoimmune disease and lymphoid malignancy
- 31 May 1991
- journal article
- review article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 59 (2), 173-186
- https://doi.org/10.1016/0090-1229(91)90016-4
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoireImmunology Today, 1989
- Stable Expression and Somatic Hypermutation of Antibody V Regions in B-Cell Developmental PathwaysAnnual Review of Immunology, 1989
- Probing the Human B-Cell Repertoire with EBV: Polyreactive Antibodies and CD5+ B LymphocytesAnnual Review of Immunology, 1989
- Phenotypic and Functional Characterization of Human LEUI (CD5) B CellsImmunological Reviews, 1986
- The LY‐1B Cell LineageImmunological Reviews, 1986
- Development and Physiology of LY‐1 B and its Human Homolog, LEU‐1 BImmunological Reviews, 1986
- Peritoneal Ly‐1 B cells: Genetic control, autoantibody production, increased lambda light chain expressionEuropean Journal of Immunology, 1986
- The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice.The Journal of Experimental Medicine, 1983
- Cell-to-cell interaction controlled by immunoglobulin genes. Role of Thy-1-, Lyt-1+, Ig+ (B') cell in allotype-restricted antibody production.The Journal of Experimental Medicine, 1982
- Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia.The Journal of Experimental Medicine, 1982